Pfizer Stock

Pfizer Dividend

The Dividend of Pfizer (PFE) as of Aug 14, 2026 is 1.72 USD. In the previous year, Dividend was 1.68 USD — a change of 2.38% (higher).

Dividend

1.72USD

YoY

2.38%

Dividend yield

6.46 %

Last updated:

How much dividend does Pfizer 2026 pay?

According to the latest status from August 2026, Pfizer paid a total of 1.72 USD per share in dividends within the last 12 months. With the current Pfizer price of 26.62 USD, this corresponds to a dividend yield of 6.54 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 6.46%. The payout ratio is around 126% of earnings. The dividend has grown at 3.1% per year over the past 19 years.

Historical Pfizer Dividends

A dividend is paid times per year. Last year, the payout months were February, June, August and December.

PaydateDividend
6/8/20260.43USD
2/23/20260.43USD
12/7/20250.43USD
8/25/20250.43USD
6/9/20250.43USD
2/24/20250.43USD
12/8/20240.42USD
8/26/20240.42USD
6/9/20240.42USD
2/25/20240.42USD
12/9/20230.41USD
12/8/20230.41USD
8/27/20230.41USD
6/11/20230.41USD
2/26/20230.41USD
12/3/20220.40USD
8/28/20220.40USD
6/12/20220.40USD
2/27/20220.40USD
12/4/20210.39USD
...

Pfizer dividend history and estimates

In 2025, Pfizer paid a dividend amounting to 1.72 USD. Dividend means that Pfizer distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
1.56 USD
0.00 USD
Jan 1, 2022
1.60 USD
0.00 USD
Jan 1, 2023
2.05 USD
0.00 USD
Jan 1, 2024
1.68 USD
0.00 USD
Jan 1, 2025
1.72 USD
0.00 USD
Jan 1, 2026 (e)
0.43 USD
1.29 USD
Jan 1, 2027 (e)
0.00 USD
1.76 USD
Jan 1, 2028 (e)
0.00 USD
1.80 USD

Is the Pfizer Dividend Safe?

Pfizer has been increasing the dividend for 1 years.

Over the past 10 years, Pfizer has increased it by an annual 4.38%.

Over a five-year period, the distribution rose by 2.50%.

Analysts expect a Dividend Increase of 0.00% for the current fiscal year.

Pfizer dividend payout ratio

In 2025, Pfizer had a payout ratio of 125.87%. The payout ratio indicates the percentage of the company's profits that Pfizer distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
40.63 %
Jan 1, 2022
29.30 %
Jan 1, 2023
542.73 %
Jan 1, 2024
119.46 %
Jan 1, 2025
125.87 %
Jan 1, 2026 (e)
57.88 %
Jan 1, 2027 (e)
60.90 %
Jan 1, 2028 (e)
74.01 %

Dividend Details

Understanding Pfizer's Dividend Distributions

Pfizer’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Pfizer's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Pfizer's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Pfizer’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Pfizer Stock analysis

What does Pfizer do? Pfizer Inc, one of the world's largest and most well-known pharmaceutical companies, has made significant advancements in the medical industry throughout its approximately 170-year history. The company is headquartered in New York City and has offices in over 150 countries. Pfizer was founded in 1849 by two cousins, Charles Pfizer and Charles Erhart, who opened their first factory in Brooklyn to produce pure crystalline chinasalt. They later expanded their business and began synthesizing chemical compounds, leading them to enter the pharmaceutical industry. In the following years, Pfizer made some significant discoveries, including the synthesis of antibiotics such as penicillin and terramycin. In the 1990s, the company expanded its portfolio and became a leading provider of prescription drugs, immunological medications, and animal health products. Today, the company focuses on three core areas: innovative health products, patented medications, and generic products. Pfizer invests millions of dollars in research and development of new and innovative treatment options, including cancer drugs, therapies for neurological disorders, cardiovascular diseases, and immunology products. Another important aspect of Pfizer's business model is its partnerships with other companies and organizations. The company works closely with universities, research institutions, governments, and other companies to form partnerships that allow for collaborative development of new products. Some of Pfizer's most well-known products include Viagra, Lipitor, Celebrex, Zoloft, and Lyrica. Viagra is used to treat erectile dysfunction in men. Lipitor is a cholesterol-lowering medication that reduces the risk of cardiovascular diseases. Celebrex is an anti-inflammatory medication used to treat pain and inflammation. Zoloft is an antidepressant used to treat various mental disorders. Lyrica is a prescription medication used to treat pain and seizures. In recent years, Pfizer has also taken a leading role in the development of vaccines against COVID-19, collaborating with the German company BioNTech to develop a promising vaccine candidate. The vaccine provides protection against the virus, particularly against severe illness. Over the years, the company has faced concerns regarding the use of medications, such as the scandal surrounding the pain reliever Vioxx, which was withdrawn in 2004 after being associated with an increased risk of cardiovascular diseases. Pfizer has since strengthened its research and development standards and partnerships to ensure the safety and efficacy of its products. In summary, Pfizer is a global player in the pharmaceutical industry. The company heavily invests in research and development of new products to provide innovative treatment options, secures patents, and simultaneously keeps its portfolio up-to-date with generic products to remain competitive in the industry. The company will continue to contribute to improving healthcare worldwide by developing lifesaving medications and vaccines that enable people to lead better lives. Pfizer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pfizer stock

Over the past 12 months, Pfizer paid a dividend of 1.72 USD . This corresponds to a dividend yield of about 6.46 %. For the coming 12 months, Pfizer is expected to pay a dividend of 1.76 USD.

The current dividend yield of Pfizer is 6.46 %.

Pfizer pays a dividend, distributed in the months of , , , .

Pfizer paid dividends every year for the past 36 years.

For the upcoming 12 months, dividends amounting to 1.76 USD are expected. This corresponds to a dividend yield of 6.69 %.

Pfizer is assigned to the 'Health' sector.

In the year 2025, Pfizer distributed 1.69 USD as dividends.

The dividends of Pfizer are distributed in USD.

Dividend calendar 2026
Access this data via the Eulerpool API

All Key Metrics — Pfizer